Discovery of a PROTAC degrader for METTL3-METTL14 complex
Authors:
Top Cited Papers
- 8 January 2024
- journal article
- research article
- Published by Elsevier in Cell Chemical Biology
- Vol. 31 (1) , 177-183.e17
Abstract
No abstract availableKeywords
Funding Information
- Program of Shanghai Subject Chief Scientist (22XD1425300)
- Natural Science Foundation of Shanghai Municipality (21ZR1475500, 81991523)
- National Natural Science Foundation of China (22277128, 82173835)
- China Postdoctoral Science Foundation (2021M703353)
- Science and Technology Commission of Shanghai Municipality (CN202210956384.9)
- Health and Family Planning Commission of Sichuan Province (2019CXJQ02)
This publication has 27 references indexed in Scilit:
- METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A ModificationCell Stem Cell, 2018
- Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation controlNature, 2017
- RNA N6‐methyladenosine methyltransferase‐like 3 promotes liver cancer progression through YTHDF2‐dependent posttranscriptional silencing of SOCS2Hepatology, 2017
- The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cellsNature Medicine, 2017
- Regulatory Role of N6-methyladenosine (m6A) Methylation in RNA Processing and Human DiseasesJournal of Cellular Biochemistry, 2017
- Structural basis of N6-adenosine methylation by the METTL3–METTL14 complexNature, 2016
- The m 6 A Methyltransferase METTL3 Promotes Translation in Human Cancer CellsMolecular Cell, 2016
- m 6 A mRNA methylation facilitates resolution of naïve pluripotency toward differentiationScience, 2015
- Perturbation of m6A Writers Reveals Two Distinct Classes of mRNA Methylation at Internal and 5′ SitesCell Reports, 2014
- Grand Challenge Commentary: RNA epigenetics?Nature Chemical Biology, 2010